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potential medicinal activity of plants?
A case study of amaryllidaceae
Nina Rønsted1*, Matthew R E Symonds3, Trine Birkholm2, Søren Brøgger Christensen2, Alan W Meerow4,5,
Marianne Molander2, Per Mølgaard2, Gitte Petersen1, Nina Rasmussen2, Johannes van Staden6, Gary I Stafford1
and Anna K Jäger2Abstract
Background: During evolution, plants and other organisms have developed a diversity of chemical defences,
leading to the evolution of various groups of specialized metabolites selected for their endogenous biological
function. A correlation between phylogeny and biosynthetic pathways could offer a predictive approach enabling
more efficient selection of plants for the development of traditional medicine and lead discovery. However, this
relationship has rarely been rigorously tested and the potential predictive power is consequently unknown.
Results: We produced a phylogenetic hypothesis for the medicinally important plant subfamily Amaryllidoideae
(Amaryllidaceae) based on parsimony and Bayesian analysis of nuclear, plastid, and mitochondrial DNA sequences
of over 100 species. We tested if alkaloid diversity and activity in bioassays related to the central nervous system are
significantly correlated with phylogeny and found evidence for a significant phylogenetic signal in these traits,
although the effect is not strong.
Conclusions: Several genera are non-monophyletic emphasizing the importance of using phylogeny for
interpretation of character distribution. Alkaloid diversity and in vitro inhibition of acetylcholinesterase (AChE) and
binding to the serotonin reuptake transporter (SERT) are significantly correlated with phylogeny. This has
implications for the use of phylogenies to interpret chemical evolution and biosynthetic pathways, to select
candidate taxa for lead discovery, and to make recommendations for policies regarding traditional use and
conservation priorities.
Keywords: Amaryllidaceae, Phylogeny, Chemical diversity, Prediction, Lead discoveryBackground
During evolution, plants and other organisms have devel-
oped a diversity of chemical defence lines, leading to the
evolution of various groups of specialized metabolites
such as alkaloids, terpenoids, and phenolics, selected for
their endogenous biological function [1-7]. Intuitively, a
correlation between phylogeny and biosynthetic pathways
is sometimes assumed [1,8-10] and could offer a predictive
approach enabling deduction of biosynthetic pathways* Correspondence: nronsted@snm.ku.dk
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reproduction in any medium, provided the or[6,11-15], defence against herbivores [16,17], more effi-
cient selection of plants for the development of traditional
medicine and lead discovery [18-22] as well as inform con-
servation priorities [23].
Several studies have confirmed the usefulness of specia-
lized metabolites such as glucosinolates, iridoids, sesqui-
terpene lactones, flavonoids, and phenolics to support
molecular based phylogenies contradicting morphologic
patterns [11,12,24-29]. On the contrary, several studies
have found inconsistency of specialized metabolite profiles
at various taxonomic levels and indicated that specializedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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be poorly correlated with plant phylogeny [6,7,13,30].
Lack of congruence between specialized chemistry and
phylogeny may be caused by several different phenom-
ena. One contributing factor is convergent evolution by
which the same or similar traits originate independently
in taxa that are not necessarily closely related, often in
response to similar environmental challenges [17,31]. A
striking example of convergent evolution is the common
use of the sex pheromone (Z)-7-dodecen-l-yl acetate by
over 120 species of primarily Lepidopteran insects and
female Asian elephants, Elephas maximus [32]. In rela-
tion to plants, well known convergent morphological
adaptations are the occurrence of prickles, thorns, and
spines, which have evolved to avoid or limit herbivory
[33], succulence as adaptation to dry environments in
both North American Cactaceae and African Euphorbia
[34,35], and insectivorous plants, which have evolved
several times in response to a nitrogen-deficient envir-
onment [36]. Likewise, chemical defence lines may also
have arisen independently in unrelated taxa, and conver-
gent evolution in plant specialized metabolism appears
to be surprisingly common [6,17,31,37]. For example,
the ability to produce cyanogenic glycosides appears to
have evolved independently in many different plant fam-
ilies [17,31].
However, convergent evolution can be difficult to ver-
ify because absence of evidence is not evidence of ab-
sence and it is possible that some compounds presently
considered to be limited to some lineages are indeed
more universally found in plants [31]. Specialized com-
pounds are not continuously expressed, but may be pro-
duced as a response to herbivory or other damage, the
expression may also be dependent on the environment
[38] and plants often use a combination of several defen-
sive traits [7,17]. In addition, chemosystematic data are
scattered in the literature and negative results are often
not reported. Absence or presence of a compound is also
dependent on the amount of plant material investigated
as well as the detection limit of the analytical methods
[27,39]. Finally, the existence of several different phyto-
chemical methods can cause inconsistence in the results
reported in the literature.
Nevertheless, reports of incongruence between phyto-
chemistry and phylogeny have questioned the degree of
correlation between phylogeny and specialized metabo-
lites, indicating that such a correlation cannot simply be
assumed [6]. However, this relationship has rarely been
tested because of lack of accurate estimates of phylogeny
and corresponding chemical data; lack of tradition for
interdisciplinary studies bridging botany, chemistry, and
molecular systematics; and appropriate statistical tools.
Consequently, the potential predictive power is un-
known [17]. In the present study, we use Amaryllidaceaesubfamily Amaryllidoideae as a model system for testing
the correlation between phylogenetic and chemical di-
versity and biological activity.
Amaryllidaceae subfamily Amaryllidoideae sensu APG III
[40] (formerly recognized as a separate family, Amaryllida-
ceae J.St.-Hil.) is a widely distributed subfamily of 59 genera
and about 850 species. Amaryllidoideae has centres of di-
versity in South Africa, South America, particularly in the
Andean region, and in the Mediterranean, three of the
recognized hotspots of biodiversity on Earth [41,42] (www.
biodiversityhotspots.org). Plants of the Amaryllidoideae are
used in traditional medicine to treat mental problems, pri-
marily in Southern Africa [43,44]. The traditional use of
plants of Amaryllidoideae has been related to their unique
and subfamily specific alkaloid chemistry (Figure 1). Over
500 alkaloids have been described from various species and
have been subdivided into 18 major types based on hypo-
thetical biosynthetic pathways [45-47]. Extracts or isolated
alkaloids of Amaryllidaceae species have shown activity
in vitro in a range of assays related to disorders of the cen-
tral nervous system, primarily Alzheimers disease (inhib-
ition of acetylcholinesterase, AChE) [21,48-51], and anxiety
and depression (affinity to the serotonin re-uptake trans-
porter, SERT) [21,52,53]. Galanthamine is registered in a
number of countries as an AChE inhibitor (Reminyl or
Rezadyne; Janssen Pharmaceutica) [54]. Another Amarylli-
daceous alkaloid, sanguinine (9-O-demethylgalanthamine),
is shown to be a ten times more potent inhibitor of AChE
than galanthamine in vitro [55].
Amaryllidaceae subfamily Amaryllidoideae is therefore
an ideal model system for comparing phylogenetic and
chemical diversity with bioactivity. Previous molecular
phylogenetic studies based on plastid gene regions (rbcL,
trnLF, and ndhF) have confirmed Amaryllidoideae as
monophyletic and resolved many taxa into geographic-
ally confined monophyletic groups [42,56]. The African
tribe Amaryllideae has been well supported as sister
group to the remaining taxa. However, the relationship
among several other early diverging lineages, in particu-
lar the African tribes Haemantheae and Cyrtantheae,
and the Australasian Calostemmateae are not well sup-
ported by previous studies and remain problematic [42].
In a study by Meerow and Snijman [42] based on parsi-
mony analysis of plastid ndhF sequences, Amaryllideae
also resolved as sister to the remainder of the subfamily.
The next major split resolved a clade with American and
Eurasian subclades, and an African/Australasian clade
with Cyrtantheae as sister to a Haemantheae/Calostem-
mateae clade. However, this African/Australasian clade
was not supported by bootstrap analysis.
The objectives of the present study were: (1) to pro-
duce a comprehensive and well supported phylogenetic
hypothesis of Amaryllidaceae subfamily Amaryllidoideae
based on total evidence from DNA regions from all
Figure 1 Alkaloid types recovered in the present study. Alkaloids were classified to type according to the hypothetical biosynthetic pathways
proposed by Jin [45,46]. Marvin was used for drawing and displaying chemical structures, Marvin 5.9.0, 2012, ChemAxon (http://www.chemaxon.
com).
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phylogenetic and chemical diversity and central nervous
system (CNS) related activities.
Results
Phylogeny
The ITS region was the most informative region fol-
lowed by the matK region (Table 1). The trnLF and the
nad1 regions resolved 10% or less of the clades with
strong support defined as≥ 90% bootstrap support.Table 1 Details of the matrices included in this study
Matrix # taxa # aligned
characters
# of PPI1
(%)
# MP
trees
ITS 105 953 502 (53) 6520
trnLF 106 1163 185 (16) 470
matK 105 2019 295 (15) 9940
Plastid combined 107 3182 480 (15) 3620
nad1 104 1726 53 (3) 8330
Total evidence 109 5861 1086 (19) 554
1PPI: potentially parsimony informative characters. 2CI: Consistency index. 3RI: Reten
with > 50% BS (bootstrap support) and with≥ 90% BS are proportions of the possibThere were no strongly supported conflicts among any
regions (Bayesian consensus tree with posterior prob-
abilities and parsimony bootstrap consensus tree for the
total evidence analysis and bootstrap consensus trees of
individual regions are provided as Additional file 1:
Figures S1-S7). The number of resolved clades (87%;
Table 1) and the number of resolved clades supported
by ≥ 90% bootstrap (62%) was highest in the total evi-
dence analysis, which was also the only analysis that
resolved all the major lineages. The Bayesian analysis ofLength of
MP trees
CI2 RI3 Percent clades
with > 50% BS4
Percent clades
with≥ 90% BS4
2537 0.42 0.82 78 55
601 0.70 0.86 33 10
922 0.74 0.90 67 39
1544 0.71 0.88 76 45
275 0.79 0.97 28 7
4454 0.53 0.85 87 62
tion index. 4Percent of resolved clades in the Bootstrap consensus tree
le number of clades (# taxa −1).
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topology as parsimony analysis and all major clades
were strongly supported by Bayesian analysis (Figure 2;
Additional file 1: Figures S1 and S2).
The topology (Figure 2) of the total evidence analysis
largely supports previous studies [42,56]. The African
tribe Amaryllideae (100% BS; PP = 1.00) is sister to the re-
mainder of the Amaryllidoideae (100% BS; PP = 1.00),
and this is strongly supported by all analyses. The next
major split resolves an American clade (66% BS; PP =
0.99) and a Eurasian clade (65% BS; PP = 1.00) as sisters
(100% BS; PP = 1.00) and a clade (66% BS; PP = 1.00) with
the African monogeneric tribe Cyrtantheae (100% BS;
PP = 1.00), and tribe Haemantheae (100% BS; PP = 1.00)
as sisters (100% BS; PP = 1.00), and the Australasian tribe
Calostemmateae (100% BS; PP = 1.00) as sister to these.
In the ITS analysis (Additional file 1: Figure S3), tribe
Amaryllideae (100% BS) is sister to the remainder of
Amaryllidoideae (61% BS). Within the remainder of
Amaryllidoideae, tribe Calostemmateae (100% BS) is sis-
ter to a clade (54% BS) including tribes Cyrtantheae
(100% BS), Haemantheae 95% BS) and the American and
European Amaryllidoideae. Tribes Cyrtantheae and Hae-
mantheae are sisters (96% BS). In the combined plastid
analysis (Additional file 1: Figure S6), Cyrtantheae is sis-
ter to the remainder of Amaryllidoideae except tribe Amar-
yllideae (75% BS). In both the matK (Additional file 1:
Figure S4 supporting online material) and the combined
plastid analysis tribe Calostemmateae is sister to tribe Hae-
mantheae (matK: 70% BS; plastid: 94% BS).
The low bootstrap support (65%) for the Eurasian clade
in the total evidence analysis (Figure 2, Additional file 1:
Figure S2) may be caused by uncertainty in the place-
ment of the genus Lycoris. The remainder of the Eurasian
clade is strongly supported in all analyses except trnLF
and nad1, which are the two regions providing the least
resolution and support in general (Additional file 1:
Figures S3-S7 in the supporting online material).
Relationship of phylogeny to chemistry and bioactivity
The relationship of individual types of compounds and
biological activity could be assessed using the D metric
developed to deal with discrete binary characters [57]. D
is equal to 1 if the observed chemical component has a
random distribution (i.e. no phylogenetic signal). D is
equal to 0 if the component is distributed exactly as
would be predicted under a Brownian motion model of
gradual divergent evolution (i.e. strong phylogenetic sig-
nal). See Materials and Methods for details. Of the seven
alkaloid types which are found in more than one species
we found evidence for some phylogenetic signal of five
types (Table 2a) [57]. With the exception of tazettine
and galanthindole, D values were significantly different
from that expected under a random distribution of thecomponents across the phylogenetic tree (D= 1). Inhib-
ition of acetylcholinesterase (AChE) and binding to the
serotonin re-uptake transporter (SERT) were used as
proxies for biological activity. Both measures of bioactiv-
ity, AChE activity and SERT activity also displayed sig-
nificant phylogenetic signal (Table 2b). However, in none
of the above cases was the phylogenetic signal suffi-
ciently strong to be considered as indistinguishable from
a Brownian motion model of evolution, where traits are
strongly ‘clumped’ on the phylogeny (and D= 0) [57].
There was a statistically highly significant correlation be-
tween differences in chemical profile and phylogenetic dis-
tance, indicating that closely-related species tend to have
more similar chemical profiles than more distantly-related
species, although the effect was not strong (Mantel test:
r = 0.085, p = 0.002). There was also statistically significant
correlation between chemical profile and phylogenetic dis-
tance in the genus level comparison (Mantel test:
r = 0.090, p = 0.024), although the effect was also weak.
Discussion
Phylogeny of Amaryllidoideae
For the purpose of the present study, we consider the
total evidence approach to provide the best estimate of
phylogeny and all major lineages are supported by both
parsimony and Bayesian analyses. The present study has
doubled previous sampling of Amaryllidoideae from 51
species [56] to 108 and from combined analysis of two
DNA regions [42,56] to four DNA regions representing
all three genomes. The only previous study resolving
relationships among basal lineages was based on plastid
ndhF sequences [42] and resolved Calostemmateae and
Haemantheae as sisters and tribe Cyrtantheae as sister
to these. However, in the present study (Figure 2), the
African tribes Cyrtantheae and Haemantheae are
strongly supported by both bootstrap and Bayesian pos-
terior probabilities as sister clades. Tribe Calostemma-
teae is sister to these, although this was only weakly
supported by the bootstrap, but strongly supported by
Bayesian posterior probabilities. A sister group rela-
tionship of the two African tribes Cyrtantheae and
Haemantheae and the Australasian tribe Calostemma-
teae as sister to these appears more convincing than the
alternative based on biogeography. However, in terms of
morphology there may be some room to question this
relationship. The indehiscent capsule of Calostemmateae
has more in common with the indehiscent baccate fruit
of Haemantheae (resembling the unripe fruit of Clivia,
Scadoxus, Haemanthus, and Cryptostephanus) than with
the dehiscent capsule of Cyrtanthus.
Phylogenetic signal of chemical diversity and bioactivity
Our approach to quantify overall correlation between
chemical and phylogenetic diversity has previously been
Figure 2 Phylogenetic hypothesis for Amaryllidaceae subfamily Amaryllidoideae. Obtained after 1,000,000 replicates of Bayesian inference.
Parsimony bootstrap percentages and Bayesian posterior probabilities (BS/PP) are indicated for major clades only. Examples of members are
illustrated on the right hand side.
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differences and nucleotide divergence in Bactrocera fruit
flies [58] and phylogenetic correlation of cuticular hydro-
carbon diversity in ants [59]. We have now shown the po-
tential application of this approach to explore correlations
between phylogenetic and chemical diversity of medicinal
plants.
We found significant phylogenetic signal for five out
of seven tested individual alkaloid types and for both
AChE and SERT bioactivity proxies, although the signal
was not strong enough to be indistinguishable from a
Brownian model of evolution, where traits are strongly
clumped on the phylogeny [57]. There was also a highly
significant correlation between differences in chemical
profiles and phylogenetic distance in both species and
generic level analyses. Despite this, there was often still
considerable difference in chemical make-up even be-
tween phylogenetically very close species (Figure 3) with
the average number of alkaloid types differing between
congeners being 2.26. Whereas members of some genera
such as Crinum and Galanthus have generally similar
chemical profiles, other genera such as Hippeastrum and
Narcissus have striking diversity.
An explanation for the moderate correlation found
could be either methodological artefacts or underlying
ecological or genetic differences [38]. We minimized
methodological artefacts by using the same plant acces-
sions for both phylogenetic, chemical, and bioactivity
studies, and by analysing our data with consistent meth-
ods. Chemical profiles were based on types deducted fromTable 2 Phylogenetic signal in chemistry and biological
activity determined using Fritz and Purvis’s [57] D metric
(see Materials and Methods for details)
a) Chemical components
Alkaloid group D P (D=1) P (D= 0)
Crinine 0.6768 0.021 0
Galanthamine 0.549 0 0.009
Lycorine 0.77 0.018 0
Galanthindole 1.091 0.621 0.011
Homolycorine 0.769 0.021 0
Montanine 0.572 0.002 0.01
Tazettine 0.852 0.094 0
b) Biological activity
Measure D P (D=1) P (D= 0)
AChE 0.679 0.004 0.001
SERT 0.634 0.037 0.044
D is equal to 1 if the observed chemical component has a random distribution
(i.e. no phylogenetic signal). D is equal to 0 if the component is distributed
exactly as would be predicted under a Brownian motion model of gradual
divergent evolution (i.e. strong phylogenetic signal). P values represent the
probability that the observed D value is equal to 1 or 0, respectively (P >0.05
indicates that the observed value is not significantly different from these
values).hypothetical pathways and could be an oversimplification
of the chemical diversity contained by over 500 individual
alkaloid structures known from the subfamily [45,47].
The strength of correlation could be dependent on taxo-
nomic scale. Whereas alkaloids derived from norbelladine
and its derivatives are almost exclusively restricted to the
subfamily Amaryllidoideae [45], and alkaloids with AChE
activity appear to be phylogenetically constrained within
Narcissus [18], the considerable variation at the species
and genus level found in this study corresponds well with
within species variation of alkaloid profiles in for example
Galanthus [51,60].
Evaluation of extensive historical drug data, marine nat-
ural products, medicinal plants and bioactive natural pro-
ducts suggests that drugs are derived mostly from pre-
existing drug-productive families that tend to be clustered
rather than randomly scattered in the phylogenetic tree of
life [61]. Zhu et al. [61] further suggest that efforts to iden-
tify new potential drugs can therefore be concentrated on
exploring a number of drug-productive clusters. However,
based on our results, such a strong presumed correlation
between phylogeny and bioactivity appears to be an over-
simplification, at least at the taxonomic scale tested in our
study. Based on our data for the medicinally important
plant subfamily Amaryllidoideae, it appears that phylogeny
can predict chemical diversity and bioactivity, but consid-
erable caution must be emphasized. We also suggest that
phylogenetic correlation of chemical traits of interest may
need to be assessed for a particular phylogenetic frame-
work before it is used for prediction of occurrence in un-
investigated taxa.
Application of phylogenetic prediction and in silico data
mining
A predictive approach could enable deduction of biosyn-
thetic pathways, defence against herbivores, more efficient
selection of plants for the development of traditional medi-
cine and lead discovery as well as inform conservation pri-
orities as outlined in the introduction. A plethora of data
on phylogenetic relationships, chemical constituents and
bioactivity are available through public databases (e.g., Gen-
Bank) and in the literature. Systematic in silico data mining
could enable more efficient use of predictive approaches to
speed up all of the above applications [22,61-65].
However, a methodological framework still needs to be
developed. In the present study, we have suggested an ap-
proach for testing correlations between phylogenetic and
chemical diversity and biological activity using experimen-
tal data generated for this purpose. One method for subse-
quent identification of specific nodes in phylogenies with
high bio-screening potential has been proposed by Saslis-
Lagoudakis et al. [22] using tools from community ecol-
ogy. In this approach, a matrix of ethnomedicinal use was
composed and used to identify nodes in a phylogeny of
AB
Figure 3 (See legend on next page.)
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Figure 3 Relationship between phylogenetic distance and chemical diversity (number of alkaloid group differences) for
Amaryllidaceae subfamily Amaryllidoidae. A) Scatter plot showing distribution of points and best-fit regression line. The size of each point is
proportional to the log-transformed number of data points contributing to it. B) The same data showing mean (±s.e.) number of differences for
categories of phylogenetic distance (number of substitutions per site) for ease of visualization. The overall relationship is significant. There is a
statistically highly significant correlation between differences in chemical profile and phylogenetic distance, although the effect is not strong
(Mantel test: r = 0.085, p = 0.002), indicating that closely related species tend to have more similar chemical profiles than more distantly related
species.
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related to a specific category of use than expected by
chance. This approach could be useful for identifying al-
ternative resources or substitute taxa in cases where sup-
ply of a medicinal plant or natural product of interest is
limited or where species in use are subject to conservation
concerns [22]. However, for the purpose of increasing the
chance of making truly new discoveries such as new com-
pounds and/or new activity profiles, it may be more rele-
vant to identify clades that possess activity of interest and
at the same time do not correspond to well known com-
pounds with well known activity profiles [66].
Other methods for predictive in silico data mining may
be combined with a phylogenetic selection approach, e.g.,
exploration of natural product chemical space as devel-
oped by Backlund and co-workers [65,67,68]. Another
computerized geospatial tracking tool linking bioactive
and phylogenetic diversity has been developed for micro-
organisms [63]. The concept of virtual parallel screening
developed for natural products by Rollinger [64], which
simultaneously enables fast identification of potential tar-
gets, insight into a putative molecular mechanism and es-
timation of a bioactivity profile, could allow for optimal
selection of relevant targets.
Conclusion
In conclusion, we have shown significant correlation be-
tween phylogenetic and chemical diversity and biological
activity in the medicinally important plant subfamily
Amaryllidoideae. However, a correlation cannot be
assumed for other study systems without considerable
caution or testing. This has implications for the use of
phylogenies to interpret chemical evolution and biosyn-
thetic pathways, to select candidate taxa for lead discovery,
and to make recommendations for policies regarding trad-
itional use and conservation priorities. Phylogenetic pre-
diction of chemical diversity and biological activity may
provide an evolutionary based tool alone or in combin-
ation with other recently developed tools for in silico data
mining of natural products and their bioactivity.
Methods
Taxon sampling
Specimens were collected in their natural habitat or
obtained from botanical gardens or specialist nurseries.Sampling included 108 (over 10%) of circa 850 species
in Amaryllidaceae subfamily Amaryllidoideae [69] with
Agapanthus campanulatus L. used as outgroup
(Additional file 2). Sampling represents 43 of circa 60
genera and all currently recognized tribes except
Griffineae Ravenna [41,42,56]. Samples from tribes
Galantheae and Haemantheae were partly retrieved from
previous studies [21,51]. The same accessions of plant
material were used for both molecular, chemical, and
bioactivity analysis to minimize effects of intraspecific
and ecological variation.
Phylogenetic analyses
DNA was extracted using the Qiagen DNeasy kit
(Qiagen, Copenhagen, Denmark) from 20 mg of dried
leaf fragments. Amplification and sequencing of the nu-
clear encoded ITS and plastid encoded matK and trnLF
regions followed Larsen et al. [51]. Amplification and se-
quencing of the mitochondrial nad1 region followed
Cuenca et al. [70]. Primers used for amplification and
sequencing are listed in Additional file 3. Both strands
were sequenced for each region for all taxa whenever
possible. Sequences were edited and assembled using Se-
quencer 4.8TM software (Gene Codes, Ann Arbor, MI,
USA). All sequences are deposited in GenBank and ac-
cession numbers JX464256- JX464610 are listed in
Additional file 2. Sequences were aligned using default
options in MUSCLE [71] as implemented in the software
SeaView [72].
Phylogenetic analyses were conducted using both par-
simony and Bayesian inference. Most parsimonious trees
(MP) were obtained with PAUP v. 4.0b10 [73] using
1,000 replicates of random taxon addition sequence and
TBR branch swapping saving multiple trees. All charac-
ters were included in the analyses and gaps were treated
as missing data. We analysed the four regions separately
to identify strongly supported phylogenetic conflicts
among the regions, prior to performing a combined total
evidence analysis. By using total evidence the explana-
tory and descriptive power of the data is maximized
[74]. Bootstrap analyses [75] of the four individual data-
sets and the combined dataset were carried out using
1,000 replicates. Bayesian analysis of the combined data-
set was performed with MrBayes 3.1.2 [76]. We first
selected the best fitting model (GTR+ I +G; Parameters:
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using the Akaike criterion (AIC) in Modeltest v. 3.8 [77].
The analysis was performed with 1,000,000 generations
on four Monte Carlo Markov chains. The average stand-
ard deviation of the split frequencies was 0.01 after
232,000 generations and < 0.005 after 1 million genera-
tions corresponding to an effective sample size of 115
using the software Tracer v. 1.5.0 [78]. The first 2,500
(25%) trees of low posterior probability were deleted and
all remaining trees were imported into PAUP. A majority
rule consensus tree was produced showing the posterior
probabilities (PP) of all observed bi-partitions. We also
performed a partitioned analysis allowing different mod-
els for the three genomes. However, in consideration of
the limited information present in our plastid and mito-
chondrial datasets (Table 1), partition rich strategies are
not always the best ones and in some cases less complex
strategies have performed better [79,80]. Although the
Bayesian MCMC approach is good at handling complex
models, there is a risk of over-parameterization, which
can result in problems with convergence and excessive
variance in parameter estimates [81].
Chemical diversity
Alkaloids were extracted from 300 mg dried bulb scales
using 0.1% H2SO4 and clean-up on ion-exchange solid
phase columns as described by Larsen et al. [51]. All
extracts were concentrated under vacuum until dryness
and re-dissolved to a standard concentration of
5 mg ml-1 in MeOH. Alkaloid profiles were obtained by
gas chromatography–mass spectrometry (GC-MS) as
described by Larsen et al. [51] using a method developed
by Berkov et al. [82]. Alkaloids were identified to type by
comparison with the NIST 08 Mass Spectral Search Pro-
gram, version 2.0 (NIST, Gaithersburg, Maryland) and
with published spectral data. Alkaloid structures were
scored to one of eighteen types (Figure 1) proposed by
Jin [45,46] based on hypothetical biosynthetic pathways
[51]. Only nine of the eighteen alkaloid types were
recorded in the present study (Figure 1). Each type show
characteristic fragmentation patterns in the MS-spectra
[83]. In most of the cases, the database proposals with
highest similarity could therefore be used to score the
candidate structure indirectly to one of the types. Candi-
date structures were excluded from the profile if they
could not be scored unambiguously to types.
In vitro biological activity
AChE inhibition and SERT affinity of the standardized al-
kaloid extracts were tested using published methods [21].
AChE activity was conducted using isolated acetylcholin-
esterase (Electrophorus electricus, Sigma, Germany) and
SERT activity using homogenates of whole rat brains except
cerebellum. Galanthamine and fluoxetine hydrochloridewere used as positive standards in the AChE and SERT
assays, respectively. Data were analysed with the software
package GraFit 5 (Erithacus Software Ltd.). Activity values
are means of three individual determinations each per-
formed in triplicate. In an initial screening, AChE inhibition
was defined as minimum 50% inhibition at a concentration
of 1.0 μg ml-1. Subsequently IC50 values were determined
for all extracts deemed active according the initial screen-
ing. IC50 values < 50 μg ml
-1 was considered active for the
analysis. SERT activity was defined as more than 85% bind-
ing of extract at 5 mg ml-1. Subsequently IC50 values were
determined for all extracts deemed active according the ini-
tial screening. IC50 values < 50 μg ml
-1 was considered ac-
tive for the analysis. These activity levels were designed to
reflect the observed level of activity in the present study
and do not necessarily reflect levels of pharmacological
relevance, but within the range of proposed ecological rele-
vance [84]. SERT activity data were not determined for
eight species of Narcissus and these samples were pruned
from the phylogenetic trees in the correlation tests.
Phylogenetic signal
We assessed the relationship of phylogeny to chemical
diversity and biological activity by calculating the phylo-
genetic signal present for individual alkaloid types and
types of biological activity. Each alkaloid type was coded
as being either present (1) or absent (0) for each species.
Likewise, for biological activity, species were scored for
the presence or absence of AChE inhibition or SERT
binding activity. Two of the alkaloid traits (belladine and
cherylline) are found only in one species each, rendering
calculation of phylogenetic signal for these traits mean-
ingless, so they were not included in this part of the
analysis.
To quantify phylogenetic signal we used the recently
developed D metric [57], specifically developed to deal
with discrete binary traits. D is calculated as follows:
D ¼ sobs  sbð Þ
sr sbð Þ
where sobs is the observed number of changes in the bin-
ary trait (here, a chemical component) across the ultra-
metric phylogeny, sr is the mean number of changes
generated from 1000 random permutations of the spe-
cies values at the tips of the phylogeny, and sb is the
mean number of changes generated from 1000 simula-
tions of the evolution for the character by a Brownian
motion model of evolution with likelihood of change
being specified as that which produces the same number
of tip species with each character state as the observed
pattern. A D value of 1 (sobs ¼ sr ) indicates that the trait
has evolved in a way that cannot be distinguished from a
random manner (i.e., no phylogenetic signal), whilst a D
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in a phylogenetically highly correlated manner. Estima-
tion of whether D differs significantly from 1 or 0 is
achieved by evaluating where the observed number of
changes (sobs) fits within the distribution of the 1000
generated sr and sb values respectively. Thus if 95% or
more values of sr are greater than sobs then P
(D= 1) ≤ 0.05 and the trait is significantly more phylo-
genetically structured than random expectation. Calcula-
tion of D was carried out using the packages caper [85]
and ape [86] in the R v2.14.0 framework [87].
We also quantified the relationship between overall
chemical profile and phylogeny following an approach
used to study the evolution of pheromone chemical diver-
sity [57,58]. We constructed pairwise matrices; one of
ultrametric phylogenetic distances (summed branch
lengths) between species, and the other of chemical differ-
ence calculated as the binary squared Euclidean distance
(i.e., the total number of alkaloid types that are absent in
one taxon but present in another and vice versa). In
addition to using all included species as terminal taxa, we
also pruned the phylogenetic tree to genera and compared
the resulting distance matrix to summed chemical profiles
for each genus. In the case of polyphyletic genera both
clades were retained. The correlation between phylogen-
etic distance and chemical difference was calculated using
Mantel tests, with rows and columns of the distance
matrix being randomly perturbed and the correlation co-
efficient recalculated 999 times to generate a null fre-
quency distribution. These tests were performed using the
program GenAlEx [88].
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